Persephone Biosciences
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Persephone Biosciences sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
Persephone Biosciences: 6 sponsored US clinical trials, 2 recruiting.
Persephone Biosciences sponsors 6 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 1 completed. The most-studied condition in this pipeline is Gastrointestinal Tolerance of Probiotics in Infants, with 1 trials.
Upper-quartile sponsor footprint
Persephone Biosciences sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
6 total, page 1 of 1
ARGONAUT: Stool and Blood Sample Bank for Cancer Patients
NCT04638751
Development and Analysis of a Stool Bank for Cancer Patients
NCT04291755
Evaluating the Impact of Synbiotic Supplementation on Infants and Toddlers
NCT06746285
My Baby Biome: Infant Stool Samples for Microbiome Health (MBB)
NCT05472688
Ambrosia: Evaluating the Effects of a Food-As-Medicine Platform on Gut Microbiome Composition and Metabolism
NCT06091813
Vaccine Observation to Include All Communities for Equitable Science
NCT04770649
What is open in the Persephone Biosciences pipeline
2 recruiting of 6 indexed (33% open); 1 completed (17%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Gastrointestinal Tolerance of Probiotics in Infants (1 trial), 7 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Persephone Biosciences: open-pipeline peers nationwide
Peers matched on 6 registered trials and 33% open enrollment, not the therapeutic-area sidebar.
Persephone Biosciences sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 trials (± recruiting share)
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors near 33% open enrollment (± trial volume)
- Aadi Bioscience · 33% recruiting · 9 trials
- Aaron Cook · 33% recruiting · 3 trials
- Abivax S.A. · 33% recruiting · 6 trials
- Actuated Medical · 33% recruiting · 3 trials
Related
What to do with this Persephone Biosciences page
6 registered trials is a research-attention snapshot, not an endorsement of Persephone Biosciences or any single study.
- 2 of Persephone Biosciences's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Gastrointestinal Tolerance of Probiotics in Infants is the condition Persephone Biosciences studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Gastrointestinal Tolerance of Probiotics in Infants trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Persephone Biosciences pipeline card: 6 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.